1. Home
  2. Analysis

Hyperthyroid and drugs of ingredients of aprepitant (a real world drug study)


Summary:

Hyperthyroid is found among people who take drugs with ingredients of aprepitant, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 20,492 people who have side effects when taking drugs with ingredients of aprepitant from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Aponvie, Aprepitant, Cinvanti, Emend.

On Jun, 25, 2026

20,492 people reported to have side effects when taking drugs with ingredients of aprepitant.
Among them, 33 people (0.16%) have Hyperthyroid

What is Hyperthyroid?

Hyperthyroid is found to be associated with 1,091 drugs and 1,420 conditions by eHealthMe. Check the latest studies of Hyperthyroid.

Number of reports submitted per year:

Could drugs with ingredients of aprepitant cause Hyperthyroid?

Time on drugs with ingredients of aprepitant when people have Hyperthyroid *:

  • < 1 month: 86.96 %
  • 1 - 6 months: 13.04 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hyperthyroid when taking drugs with ingredients of aprepitant *:

  • female: 59.38 %
  • male: 40.62 %

Age of people who have Hyperthyroid when taking drugs with ingredients of aprepitant *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.38 %
  • 40-49: 3.12 %
  • 50-59: 25.0 %
  • 60+: 62.5 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Lung Cancer - Non-Small Cell (lung cancer): 12 people, 36.36%
  2. Headache (pain in head): 10 people, 30.30%
  3. Abdominal Pain: 9 people, 27.27%
  4. Constipation: 9 people, 27.27%
  5. Allergic Rhinitis: 7 people, 21.21%
  6. Anal Erosion: 7 people, 21.21%
  7. Anal Inflammation: 7 people, 21.21%
  8. Dermatitis Acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis): 7 people, 21.21%
  9. Dry Skin: 7 people, 21.21%
  10. Stomatitis (inflammation of mucous membrane of mouth): 7 people, 21.21%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Carboplatin: 15 people, 45.45%
  2. Paclitaxel: 9 people, 27.27%
  3. Polaramine: 7 people, 21.21%
  4. Vibramycin: 7 people, 21.21%
  5. Ondansetron: 7 people, 21.21%
  6. Opdivo: 7 people, 21.21%
  7. Methylprednisolone: 6 people, 18.18%
  8. Yervoy: 6 people, 18.18%
  9. Nexium: 6 people, 18.18%
  10. Ranitidine Hydrochloride: 6 people, 18.18%

Other side effects people have besides Hyperthyroid *:

You may use this to check any potential undetected side effects.

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 27.27%
  2. Colitis (inflammation of colon): 7 people, 21.21%
  3. Febrile Neutropenia (fever with reduced white blood cells): 7 people, 21.21%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 12.12%
  5. Metastases To Meninges (cancer spreads to meninges): 3 people, 9.09%
  6. Aspartate Aminotransferase Increased: 3 people, 9.09%
  7. Alanine Aminotransferase Increased: 3 people, 9.09%
  8. Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 6.06%
  9. Mucosal Inflammation (infection of mucous membrane): 2 people, 6.06%
  10. Oncologic Complication: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of aprepitant, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.